|
Pfizer,
Wyeth CEOs See Drop in Compensation
Pfizer CEO Jeff Kindler’s 2007
compensation package was worth $9.5 million, down from $9.8 million in
2006, according to the company’s proxy. Vice chairman David Shedlarz
left the company last year; his exit package was worth $34.2 million.
Research chief John LaMattina also left Pfizer last year, with an exit
package worth $22.6 million. See The
Wall Street Journal Health Blog (3/14)
The total value of Wyeth CEO Robert
Essner’s compensation package was $24.1 million last year, down from
$32.9 million the year before. Essner stepped down as CEO on January
1, 2008. His replacement Bernard Poussot, formerly president and vice
chairman, saw his package decline from $14.4 million in 2006 to $12.7
million last year. See The
Wall Street Journal Health Blog (3/14)
The total value of J&J CEO Bill
Weldon’s 2007 pay package rose more than 10%, to $31.9 million,
according to J&J’s proxy statement. J&J shares gained less
than 1% on the year. See The
Wall Street Journal Health Blog (3/13)
|
